Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Hammer

Showing results (101-110 of 263) with videos related to

Pageof 27
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1983
Surface modulation of classical pathway activation: C2 and C3 convertase formation and regulation on sheep, guinea pig, and human erythrocytesE J Brown, J Ramsey, C H Hammer, et al.
Acta Crystallographica. Section D, Biological Crystallography|April 9, 2008
Towards a rational approach for heavy-atom derivative screening in protein crystallographyJohnson Agniswamy, M Gordon Joyce, Carl H Hammer, et al.
Journal of Immunological Methods|May 4, 1987
Purification of C1 inhibitor. A new approach for the isolation of this biologically important plasma protease inhibitorL J Prograis, C H Hammer, K Katusha, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 1, 1981
Homologous species restriction in lysis of erythrocytes by terminal complement proteinsG M Hänsch, C H Hammer, P Vanguri, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 1, 1983
Activation of the fifth and sixth components of the human complement system: C6-dependent cleavage of C5 in acid and the formation of a bimolecular lytic complex, C5b,6aC H Hammer, G Hänsch, H D Gresham, et al.
Biochimica Et Biophysica Acta|July 21, 2004
Characterization of a lysyl aminopeptidase activity associated with phosphoglucose isomerase of Vibrio vulnificusGary P Richards, Carl H Hammer, Mark K Garfield, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 14, 2011
Lack of listing status awareness: results of a single-center survey of hemodialysis patientsA Gillespie, H Hammer, J Lee, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 1, 1976
Increased ion permeability of planar lipid bilayer membranes after treatment with the C5b-9 cytolytic attack mechanism of complementD W Michaels, A S Abramovitz, C H Hammer, et al.
The Journal of Experimental Medicine|March 1, 1982
Studies on the mechanism of bacterial resistance to complement-mediated killing. II. C8 and C9 release C5b67 from the surface of Salmonella minnesota S218 because the terminal complex does not insert into the bacterial outer membraneK A Joiner, C H Hammer, E J Brown, et al.
Infection and Immunity|August 1, 1993
TnphoA-mediated disruption of K54 capsular polysaccharide genes in Escherichia coli confers serum sensitivityT A Russo, M C Moffitt, C H Hammer, et al.
Pageof 27

Showing results (101-110 of 263) with videos related to

Sort By:
Pageof 27
Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1983
Surface modulation of classical pathway activation: C2 and C3 convertase formation and regulation on sheep, guinea pig, and human erythrocytesE J Brown, J Ramsey, C H Hammer, et al.
Acta Crystallographica. Section D, Biological Crystallography|April 9, 2008
Towards a rational approach for heavy-atom derivative screening in protein crystallographyJohnson Agniswamy, M Gordon Joyce, Carl H Hammer, et al.
Journal of Immunological Methods|May 4, 1987
Purification of C1 inhibitor. A new approach for the isolation of this biologically important plasma protease inhibitorL J Prograis, C H Hammer, K Katusha, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 1, 1981
Homologous species restriction in lysis of erythrocytes by terminal complement proteinsG M Hänsch, C H Hammer, P Vanguri, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 1, 1983
Activation of the fifth and sixth components of the human complement system: C6-dependent cleavage of C5 in acid and the formation of a bimolecular lytic complex, C5b,6aC H Hammer, G Hänsch, H D Gresham, et al.
Biochimica Et Biophysica Acta|July 21, 2004
Characterization of a lysyl aminopeptidase activity associated with phosphoglucose isomerase of Vibrio vulnificusGary P Richards, Carl H Hammer, Mark K Garfield, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 14, 2011
Lack of listing status awareness: results of a single-center survey of hemodialysis patientsA Gillespie, H Hammer, J Lee, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 1, 1976
Increased ion permeability of planar lipid bilayer membranes after treatment with the C5b-9 cytolytic attack mechanism of complementD W Michaels, A S Abramovitz, C H Hammer, et al.
The Journal of Experimental Medicine|March 1, 1982
Studies on the mechanism of bacterial resistance to complement-mediated killing. II. C8 and C9 release C5b67 from the surface of Salmonella minnesota S218 because the terminal complex does not insert into the bacterial outer membraneK A Joiner, C H Hammer, E J Brown, et al.
Infection and Immunity|August 1, 1993
TnphoA-mediated disruption of K54 capsular polysaccharide genes in Escherichia coli confers serum sensitivityT A Russo, M C Moffitt, C H Hammer, et al.
Pageof 27